logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Adalimumab/cyclophosphamide/methylprednisoloneBrain tuberculoma: 4 case reports

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2016年 / 1601卷 / 1期
关键词:
D O I:
10.1007/s40278-016-17320-9
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:18 / 18
相关论文
共 50 条
  • [21] Cyclophosphamide/rituximabVarious toxicities: 4 case reports
    Reactions Weekly, 2021, 1860 (1) : 138 - 138
  • [22] Cyclophosphamide/ifosfamideHaemorrhagic cystitis: 4 case reports
    Reactions Weekly, 2018, 1725 (1) : 103 - 103
  • [23] Cyclophosphamide/tacrolimusThrombotic microangiopathy: 4 case reports
    Reactions Weekly, 2007, 1181 (1) : 13 - 13
  • [24] Cyclophosphamide/rituximabVarious toxicities: 4 case reports
    Reactions Weekly, 2019, 1758 (1) : 125 - 125
  • [25] Cyclophosphamide/rituximabVarious toxicities: 4 case reports
    Reactions Weekly, 2016, 1630 (1) : 73 - 73
  • [26] Adalimumab/ustekinumabLatent tuberculosis infection: 4 case reports
    Reactions Weekly, 2021, 1846 (1) : 15 - 15
  • [27] Adalimumab/infliximab/methotrexateVarious toxicities: 4 case reports
    Reactions Weekly, 2020, 1788 (1) : 16 - 16
  • [28] Adalimumab/etanercept/infliximabAseptic meningitis: 4 case reports
    Reactions Weekly, 2017, 1643 (1) : 15 - 15
  • [29] Adalimumab/etanerceptInjection site reactions: 4 case reports
    Reactions Weekly, 2008, 1184 (1) : 6 - 6
  • [30] Adalimumab/etanercept/infliximabLung disorders: 4 case reports
    Reactions Weekly, 2008, 1210 (1) : 6 - 6
← 12345 →